Cargando…

Smoking Induces the Circulating Levels of Matrix Metalloproteinase-9 and Its Association with Cardiovascular Risk in Young Smokers

OBJECTIVE: Smoking causes cardiovascular risk, which may alter the stability between the production and degradation of the extracellular matrix. Matrix metalloproteinase-9 (MMP-9) is a zinc-containing endopeptidase that degrades the extracellular matrix and is involved in tissue remodelling and seve...

Descripción completa

Detalles Bibliográficos
Autores principales:	NATH, Dinesh, SHIVASEKAR, Meera, VINODHINI, V.M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808855/ https://www.ncbi.nlm.nih.gov/pubmed/36578139 http://dx.doi.org/10.4274/MMJ.galenos.2022.45057

Ejemplares similares

Role of Cigarette Smoking on Serum Angiotensin-Converting Enzyme and Its Association With Inflammation and Lipid Peroxidation
por: Nath, Dinesh, et al.
Publicado: (2022)

Matrix metalloproteinases -8, -9 and -12 in smokers and patients with Stage 0 COPD
por: Ilumets, Helen, et al.
Publicado: (2007)

Increased nasal matrix metalloproteinase-1 and -9 expression in smokers with chronic rhinosinusitis and asthma
por: Huang, Chien-Chia, et al.
Publicado: (2019)

Assessment of Matrix Metalloproteinases-8 and -9 in Gingival Crevicular Fluid of Smokers and Non-smokers with Chronic Periodontitis Using ELISA
por: Victor, Dayanand John, et al.
Publicado: (2014)

The Levels of Vitamin D, Metalloproteinase-9 and Tissue Inhibitor Metalloproteinase-1 in COPD Patients, Healthy Smokers and Non-Smokers of Indonesian Citizens
por: Arbaningsih, Sri Rezeki, et al.
Publicado: (2019)

Increased matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio in smokers with airway hyperresponsiveness and accelerated lung function decline
por: Lo, Chun-Yu, et al.
Publicado: (2018)

Circulating Matrix Metalloproteinase-9 Is Associated with Cardiovascular Risk Factors in a Middle-Aged Normal Population
por: Garvin, Peter, et al.
Publicado: (2008)

Lung matrix metalloproteinase-9 correlates with cigarette smoking and obstruction of airflow.
por: Kang, Min Jong, et al.
Publicado: (2003)

Impact of Matrix Metalloproteinase-9 during Periodontitis and Cardiovascular Diseases
por: Isola, Gaetano, et al.
Publicado: (2021)

Circulating Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Cardiac Amyloidosis
por: Tanaka, Komei, et al.
Publicado: (2013)

Correlation of matrix metalloproteinase 3 and matrix metalloproteinase 9 levels with non-motor symptoms in patients with Parkinson’s disease
por: Liu, Chuan Ze, et al.
Publicado: (2022)

Expression levels of matrix metalloproteinase-9 in human gastric carcinoma
por: CHEN, SU-ZUAN, et al.
Publicado: (2015)

Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis
por: Lorente, Leonardo, et al.
Publicado: (2009)

Elevated concentrations of serum matrix metalloproteinase-2 and -9 and their associations with circulating markers of cardiovascular diseases in chronic arsenic-exposed individuals
por: Islam, Md Shofikul, et al.
Publicado: (2015)

Circulating Matrix Metalloproteinase-2 and -9 Enzyme Activities in the Children with Ventricular Septal Defect
por: Cheng, Kun-Shan, et al.
Publicado: (2013)

Significance of Circulating and Crevicular Matrix Metalloproteinase-9 in Rheumatoid Arthritis-Chronic Periodontitis Association
por: Silosi, Isabela, et al.
Publicado: (2015)

Involvement of Matrix Metalloproteinase 9 in Vertebral Arterial Dissection With Posterior Circulation Ischemic Stroke
por: Chen, Chun‐Yu, et al.
Publicado: (2020)

Serum levels of matrix metalloproteinase 2 and matrix metalloproteinase 9 elevated in polypoidal choroidal vasculopathy but not in age-related macular degeneration
por: Zeng, Renpan, et al.
Publicado: (2013)

Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer disease
por: Provatopoulou, Xeni, et al.
Publicado: (2009)

Tissue levels of active matrix metalloproteinase-2 and -9 in colorectal cancer
por: Waas, E T, et al.
Publicado: (2002)

Serum Level of Matrix Metalloproteinase-9 in Patients with Salivary Gland Tumor
por: Mardani, Maryam, et al.
Publicado: (2014)

Plasma Levels of Matrix Metalloproteinase-9 in Children With Chronic Spontaneous Urticaria
por: Dilek, Fatih, et al.
Publicado: (2016)

Plasma levels of matrix metalloproteinase-9 are elevated in individuals with hypertensive crisis
por: Valente, Flavia Mariana, et al.
Publicado: (2020)

Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer
por: Tanioka, Y, et al.
Publicado: (2003)

Interleukin-33, matrix metalloproteinase-9, and tissue ınhibitor of matrix metalloproteinase-1 in myocardial infarction
por: Guzel, Savas, et al.
Publicado: (2013)

Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients
por: Trentini, Alessandro, et al.
Publicado: (2016)

Matrix Metalloproteinase-1 and Matrix Metalloproteinase-9 in the Aqueous Humor of Diabetic Macular Edema Patients
por: Kwon, Jin-woo, et al.
Publicado: (2016)

Matrix Metalloproteinases in COPD and atherosclerosis with emphasis on the effects of smoking
por: Kraen, M., et al.
Publicado: (2019)

Dynamic Neuroimaging Biomarkers of Smoking in Young Smokers
por: Xue, Ting, et al.
Publicado: (2020)

Matrix Metalloproteinase-9 (MMP9)—A Mediating Enzyme in Cardiovascular Disease, Cancer, and Neuropsychiatric Disorders
por: Rybakowski, Janusz K.
Publicado: (2009)

Genetic variations and plasma levels of gelatinase A (matrix metalloproteinase-2) and gelatinase B (matrix metalloproteinase-9) in proliferative diabetic retinopathy
por: Beránek, Michal, et al.
Publicado: (2008)

Important role of matrix metalloproteinase 9 in epileptogenesis
por: Wilczynski, Grzegorz M., et al.
Publicado: (2008)

Expression of Matrix Metalloproteinase-9 in Gastric Cancer
por: R, Prathipaa, et al.
Publicado: (2021)

The Effect of Thiamine, Ascorbic Acid, and the Combination of Them on the Levels of Matrix Metalloproteinase-9 (MMP-9) and Tissue Inhibitor of Matrix Metalloproteinase-1 (TIMP-1) in Sepsis Patients
por: Lubis, Bastian, et al.
Publicado: (2022)

Correlation between expression of matrix metalloproteinase-2 (MMP-2), and matrix metalloproteinase-9 (MMP-9) and angiogenesis in colorectal adenocarcinoma.
por: Kim, T. S., et al.
Publicado: (1999)

Erratum: Interleukin-33, matrix metalloproteinase-9, and tissue inhibitor of matrix metalloproteinase-1 in myocardial infarction
por: Guzel, Savas, et al.
Publicado: (2013)

Elevated Expression of Matrix Metalloproteinase-9 not Matrix Metalloproteinase-2 Contributes to Progression of Extracranial Arteriovenous Malformation
por: Wei, Ting, et al.
Publicado: (2016)

Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 in Sepsis after Major Abdominal Surgery
por: Bojic, Suzana, et al.
Publicado: (2018)

Plasma levels of matrix metalloproteinase‐9 (MMP‐9) are associated with cognitive performance in patients with schizophrenia
por: Kudo, Noriko, et al.
Publicado: (2020)

Elevated matrix metalloproteinase‐9 levels in neuronal extracellular vesicles in Alzheimer’s disease
por: Gu, Dongmei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jlp0660npmkbkujhbv6llab03b